Sur-8 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of Sur-8, a scaffold protein that plays a crucial role in Ras-MAPK (mitogen-activated protein kinase) signaling. Sur-8, also known as SHOC2, acts as a mediator in Ras signaling by interacting with Ras and other components of the MAPK pathway, facilitating the transmission of signals from membrane receptors to downstream effectors involved in cell growth, differentiation, and survival. By inhibiting Sur-8, these compounds interfere with the proper assembly and functioning of the Ras-MAPK signaling complex, thereby affecting signal transduction and altering cellular responses to extracellular stimuli.
The mechanism of Sur-8 inhibitors typically involves blocking the interaction between Sur-8 and Ras or other associated proteins within the MAPK pathway. Some inhibitors may disrupt the structural conformation of Sur-8, preventing it from serving as an effective scaffold for signaling components, while others may directly interfere with its binding sites. Researchers use Sur-8 inhibitors to explore the regulatory role of scaffold proteins in complex signaling networks, especially in pathways that control cell proliferation and differentiation. By inhibiting Sur-8, scientists can better understand the molecular mechanisms that govern Ras-MAPK signaling and how the spatial organization of signaling molecules contributes to the precision and specificity of cellular responses. These inhibitors are valuable tools for dissecting the intricate dynamics of protein-protein interactions in signal transduction pathways and for studying the broader implications of scaffold proteins like Sur-8 in cellular communication and regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that might change the methylation status of the SHOC2 gene, potentially affecting its expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
This antibiotic binds to DNA and may inhibit RNA polymerase, which could reduce the transcription of SHOC2. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can result in decreased protein synthesis, possibly affecting the production of SHOC2. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
It inhibits translational elongation, which might lead to a general decrease in protein levels, including SHOC2. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
It can modulate signaling pathways and transcription factors that may influence SHOC2 gene expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
By affecting endosomal/lysosomal pathways, chloroquine might indirectly influence SHOC2 expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
It inhibits RNA polymerase II and could lead to decreased transcription of genes such as SHOC2. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
By inhibiting JNK signaling, this compound could impact transcription factors related to SHOC2 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As a PI3K inhibitor, it might downregulate AKT/mTOR signaling, possibly impacting SHOC2 protein synthesis. | ||||||